Clinical Trials · NCT04451837
Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Region Skane
- Enrollment
- 200
- Start date
- Sep 2020
- Locations
- 1 site, Sweden
- Primary endpoint
- Hba1c